Trimix Injectable Vials Recalled for Lack of Sterility Assurance
Family Pharmacy of Statesville is recalling Trimix (Alprostadil/Papaverine/Phentolamine) injectable vials distributed in North Carolina due to lack of assurance of sterility.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The FDA classified this as a Class II recall. The hazard—lack of sterility assurance in an injectable drug—poses a direct risk of serious harm (infection, sepsis) to patients who use affected vials, meeting the threshold for Severe classification even though no illnesses are reported in the source text.
Plain-English summary
Family Pharmacy of Statesville, Inc. is recalling Trimix (Alprostadil/Papaverine/Phentolamine) 10 mcg/20 mg/1 mg injectable vials in 5 mL vials because the firm cannot assure the sterility of the product.
The affected lots are: - Lot #07232020@1 (BUD: 9/6/2020) - Lot #07282020@1 (BUD: 9/11/2020) - Lot #07282020@2 (BUD: 9/11/2020)
The product was distributed in North Carolina only. Trimix is a prescription-only injectable medication.
Patients currently using this product should contact their healthcare provider or pharmacy for guidance.
The recalled product
- Product
- Trimix (Alprostadil/Papaverine/Phentolamine) 10 mcg/20 mg/1 mg Injectable 5 mL vials, Rx only, Family Pharmacy of Statesville, Inc.
- Manufacturer
- Family Pharmacy of Statesville
- Category
- Drug — Injectable
- Hazard
- lack-of-sterility
- contamination-risk
- injection-safety
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot #:07232020@1 BUD: 9/6/2020
- 07282020@1 BUD: 9/11/2020
- 07282020@2 BUD: 9/11/2020
Distribution
Distributed in 1 state:
- NC
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27